PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1756482
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1756482
Patient Blood Management Market, By Product, By Component, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Patient Blood Management Market size was valued at USD 15,478.98 Million in 2024, expanding at a CAGR of 7.98% from 2024 to 2032.
Patient Blood Management (PBM) is a comprehensive, evidence-based approach aimed at optimizing the care of patients who may require blood transfusions. It focuses on minimizing the need for transfusions by utilizing various strategies such as improving the patient's own blood volume and quality before, during, and after medical procedures. PBM includes three main pillars: optimization of erythropoiesis (promoting the body's natural production of red blood cells), minimization of blood loss (reducing surgical and diagnostic blood loss), and patient-centered transfusion strategies (ensuring transfusions are given only when absolutely necessary). The goal of PBM is to enhance patient outcomes by improving the management of anemia, reducing the risks associated with transfusions, and promoting the use of alternatives. This approach is particularly beneficial in surgical settings, trauma care, and chronic conditions where blood management plays a vital role in recovery and overall health.
Patient Blood Management Market- Market Dynamics
Rising Prevalence of Anemia and Chronic Diseases
The increasing prevalence of anemia and chronic diseases, such as cardiovascular disorders, cancer, and kidney disease, is a major driver for the growth of the Patient Blood Management (PBM) market. These conditions often lead to significant blood loss or decreased red blood cell production, necessitating more effective blood management strategies. As the global population ages and the incidence of these diseases rises, healthcare providers are turning to PBM to optimize blood use, reduce the need for transfusions, and improve patient outcomes. PBM strategies help manage anemia through tailored therapies and interventions, reducing the risks associated with transfusions and enhancing recovery. Consequently, the growing burden of chronic diseases is driving demand for PBM solutions that focus on minimizing blood loss, improving erythropoiesis, and offering alternatives to traditional transfusions. This trend significantly impacts the market's expansion.
PATIENT BLOOD MANAGEMENT Market- Key Insights
According to our research analyst, the global Patient Blood Management Market is expected to develop at a CAGR of approximately 7.98% between 2024-2032.
Segmented by Product in 2024, the Instruments category dominated the market.
Based on End User segmentation, the Hospitals generated the most income in 2024.
Based on region, in 2024, North America was the region with the highest revenue.
Patient Blood Management Market- Segmentation Analysis:
The global Patient Blood Management market is divided into three categories: product, component, end user and region.
The Patient Blood Management (PBM) market is segmented into four key product categories: Instruments, Accessories, Reagents and Kits, and Software. Among these, Instruments are expected to dominate the market. This segment includes devices such as blood collection systems, blood processing equipment, and diagnostic instruments used to monitor and manage blood-related conditions. The dominance of instruments is attributed to their critical role in enabling accurate blood analysis, reducing blood loss, and enhancing transfusion practices in clinical settings. As PBM emphasizes minimizing blood loss and optimizing blood use, instruments are central to these objectives. Additionally, advancements in medical technologies and the growing adoption of blood-saving surgical techniques drive the demand for innovative, high-performance instruments. The importance of precise blood management in surgeries and critical care, coupled with increasing healthcare investments, positions instruments as the leading product category within the PBM market.
By End User the market is segmented into Blood Banks, Hospitals and Diagnostic Clinics and & Pathology Labs. Among these, the Hospitals segment is set to dominate. Hospitals are the primary healthcare settings where PBM practices are most extensively applied, particularly in surgical procedures, trauma care, and critical patient management. With the high volume of blood transfusions, surgeries, and patient admissions, hospitals require comprehensive PBM systems to manage blood loss, optimize blood use, and reduce transfusion-related risks. The growing adoption of PBM in hospitals is driven by the increasing number of complex surgeries, the rising incidence of chronic diseases, and the emphasis on improving patient outcomes. Additionally, hospitals are increasingly implementing advanced technologies for blood management, contributing to the expansion of PBM practices. While blood banks and diagnostic clinics also play essential roles in PBM, hospitals remain the dominant end user due to their direct involvement in patient care and treatment.
Patient Blood Management Market- Geographical Insights
Geographically, the Patient Blood Management Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.
North America is a dominant region in the Patient Blood Management (PBM) market, driven by the advanced healthcare infrastructure and the growing adoption of PBM practices in hospitals and healthcare facilities. The U.S. leads the market, where healthcare systems are increasingly focusing on reducing transfusion-related complications and optimizing patient outcomes through PBM solutions. Regulatory support from agencies like the FDA, along with rising awareness about the benefits of PBM, further fuels its adoption. Additionally, the presence of key market players and continuous technological advancements in blood management instruments contribute to North America's market leadership. The region's robust healthcare spending and an aging population requiring complex medical treatments further drive the demand for PBM solutions.
Europe is another key region in the PBM market, with significant growth attributed to a strong healthcare system, an aging population, and an increasing emphasis on minimizing blood loss and transfusions. Countries such as Germany, the U.K., and France lead the European market, with healthcare providers increasingly adopting PBM practices to enhance patient safety and reduce healthcare costs. The European Union's healthcare policies support the adoption of PBM strategies, particularly in hospitals and surgical centers. In addition, advancements in medical technology, such as blood-saving surgical instruments and diagnostic tools, play a pivotal role in driving market growth. Europe's progressive approach to healthcare and patient care ensures continued demand for PBM solutions in the region.
Patient Blood Management Market- Competitive Landscape:
The competitive dynamics of the Patient Blood Management (PBM) market are shaped by both established players and emerging innovators. Major companies like Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, and Immucor, Inc. lead the market, offering a range of advanced PBM solutions that prioritize safety, efficiency, and compliance with regulatory standards. These companies focus heavily on research and development to improve blood management systems and enhance transfusion protocols. New players are also entering the market with innovative technologies, such as advanced diagnostic tools and blood-saving surgical instruments. The competition among these companies encourages continuous product advancements and ensures a steady supply of high-quality PBM solutions. For instance, F. Hoffmann-La Roche Ltd. and Grifols, S.A. have been actively expanding their product portfolios, while B. Braun Melsungen AG and Bio-Rad Laboratories, Inc. continue to strengthen their positions through strategic acquisitions and collaborations.
Recent Developments:
In 2023, Grifols acquired 25 plasma donation centers in the U.S. from BPL Plasma Inc., enhancing its capacity by approximately 1 million liters annually. This strategic move strengthens Grifols' global leadership in plasma collection, supporting the growing demand for plasma-derived therapies. The acquisition aligns with Grifols' commitment to increasing patient access to life-saving treatments.
In October 2024, Terumo Blood and Cell Technologies introduced the Reveos(TM) Automated Blood Processing System in the U.S., in collaboration with Blood Centers of America. This innovative system automates the separation of whole blood into its components platelets, plasma, and red blood cells streamlining the process and improving efficiency. Reveos aims to enhance blood center operations and meet the increasing demand for blood products.
In August 2022, Abbott Laboratories launched a new blood testing platform designed to improve the accuracy and speed of diagnostics in patient blood management. This advanced platform supports healthcare providers in making timely and informed decisions, optimizing patient outcomes, and reducing the need for unnecessary transfusions. Abbott's innovation underscores its commitment to advancing PBM practices.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PATIENT BLOOD MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Haemonetics Corporation
- Fresenius Se & Co. KGaA
- Terumo Corporation
- Immucor, Inc.
- B. Braun Melsungen AG
- Macopharma
- Biomerieux SA
- Kaneka Corporation
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Grifols, S.A.
- F. Hoffmann-La Roche Ltd.
- Others
GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Instruments
- Blood Processing Devices
- Centrifuges
- Blood Cell Processors
- Blood Transfusion Devices
- Apheresis Machines
- Plasma & Plasma Component Separators
- Cell Salvage Systems
- Other Transfusion Devices
- Blood Culture Screening Devices
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Diagnostic & Testing Instruments
- PCR Instruments
- Hematology Analyzers
- NGS Platforms
- Blood Grouping Analyzers
- Blood Storage Devices
- Medical Refrigerators
- Medical Freezers
- Accessories
- Syringes & Needles
- Vials & Tubes
- Blood Bags
- Other Accessories
- Reagents and Kits
- Blood Culture Media
- Blood Typing Reagents
- Slide Staining Reagents
- Assay Kits
- Other Reagents
- Software
- Blood Bank Management Software
- Transfusion Management Software
- Other Software
GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
- Whole Blood & Red Blood Cells
- Plasma
GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Blood Banks
- Hospitals
- Diagnostic Clinics and & Pathology Labs
GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Patient Blood Management Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Patient Blood Management Market Snippet by Product
- 2.1.2. Patient Blood Management Market Snippet by Component
- 2.1.3. Patient Blood Management Market Snippet by End User
- 2.1.4. Patient Blood Management Market Snippet by Country
- 2.1.5. Patient Blood Management Market Snippet by Region
- 2.2. Competitive Insights
3. Patient Blood Management Key Market Trends
- 3.1. Patient Blood Management Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Patient Blood Management Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Patient Blood Management Market Opportunities
- 3.4. Patient Blood Management Market Future Trends
4. Patient Blood Management Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Patient Blood Management Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Patient Blood Management Market Landscape
- 6.1. Patient Blood Management Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Patient Blood Management Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 7.1.2. Instruments
- 7.1.2.1. Blood Processing Devices
- 7.1.2.1.1. Centrifuges
- 7.1.2.1.2. Blood Cell Processors
- 7.1.2.2. Blood Transfusion Devices
- 7.1.2.2.1. Apheresis Machines
- 7.1.2.2.2. Plasma & Plasma Component Separators
- 7.1.2.2.3. Cell Salvage Systems
- 7.1.2.2.4. Other Transfusion Devices
- 7.1.2.3. Blood Culture Screening Devices
- 7.1.2.3.1. Automated Blood Culture Systems
- 7.1.2.3.2. Supporting Laboratory Equipment
- 7.1.2.4. Diagnostic & Testing Instruments
- 7.1.2.4.1. PCR Instruments
- 7.1.2.4.2. Hematology Analyzers
- 7.1.2.4.3. NGS Platforms
- 7.1.2.4.4. Blood Grouping Analyzers
- 7.1.2.5. Blood Storage Devices
- 7.1.2.5.1. Medical Refrigerators
- 7.1.2.5.2. Medical Freezers
- 7.1.3. Accessories
- 7.1.3.1. Syringes & Needles
- 7.1.3.2. Vials & Tubes
- 7.1.3.3. Blood Bags
- 7.1.3.4. Other Accessories
- 7.1.4. Reagents and Kits
- 7.1.4.1. Blood Culture Media
- 7.1.4.2. Blood Typing Reagents
- 7.1.4.3. Slide Staining Reagents
- 7.1.4.4. Assay Kits
- 7.1.4.5. Other Reagents
- 7.1.5. Software
- 7.1.5.1. Blood Bank Management Software
- 7.1.5.2. Transfusion Management Software
- 7.1.5.3. Other Software
8. Patient Blood Management Market - By Component
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
- 8.1.2. Whole Blood & Red Blood Cells
- 8.1.3. Plasma
9. Patient Blood Management Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2. Blood Banks
- 9.1.3. Hospitals
- 9.1.4. Diagnostic Clinics and & Pathology Labs
10. Patient Blood Management Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Patient Blood Management Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Patient Blood Management Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. France
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.8.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. Italy
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.9.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. Spain
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.10.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. United Kingdom
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.11.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Russia
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.12.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Netherlands
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.13.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Sweden
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.16.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Patient Blood Management Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. South Korea
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.9.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. Japan
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.10.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Patient Blood Management Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Patient Blood Management Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Patient Blood Management Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Haemonetics Corporation
- 11.2.2. Fresenius Se & Co. KGaA
- 11.2.3. Terumo Corporation
- 11.2.4. Immucor, Inc.
- 11.2.5. B. Braun Melsungen AG
- 11.2.6. Macopharma
- 11.2.7. Biomerieux SA
- 11.2.8. Kaneka Corporation
- 11.2.9. Bio-Rad Laboratories, Inc.
- 11.2.10. Abbott Laboratories
- 11.2.11. Grifols, S.A.
- 11.2.12. F. Hoffmann-La Roche Ltd.
- 11.2.13. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
